Chevy Chase Trust Holdings LLC Grows Holdings in GE HealthCare Technologies Inc. $GEHC

Chevy Chase Trust Holdings LLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 243,192 shares of the company’s stock after buying an additional 1,948 shares during the period. Chevy Chase Trust Holdings LLC owned approximately 0.05% of GE HealthCare Technologies worth $18,013,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. JPMorgan Chase & Co. grew its stake in GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares in the last quarter. Nuveen LLC purchased a new position in GE HealthCare Technologies in the 1st quarter worth approximately $77,058,000. Eminence Capital LP grew its stake in GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after buying an additional 507,101 shares in the last quarter. Homestead Advisers Corp grew its stake in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after buying an additional 475,500 shares in the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after buying an additional 409,636 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.9%

NASDAQ:GEHC opened at $74.05 on Friday. The company has a fifty day moving average of $74.51 and a 200 day moving average of $72.03. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $33.81 billion, a P/E ratio of 15.17, a P/E/G ratio of 2.83 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the business posted $1.00 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. BTIG Research upped their price objective on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, Barclays began coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.